• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

早期阿尔茨海默病患者循环CD34+干细胞减少:造血系统对脑支持不足的证据?

Decreased circulating CD34+ stem cells in early Alzheimer's disease: Evidence for a deficient hematopoietic brain support?

作者信息

Maler J M, Spitzer P, Lewczuk P, Kornhuber J, Herrmann M, Wiltfang J

机构信息

Department of Psychiatry and Psychotherapy, University of Erlangen-Nuremberg, Erlangen, Germany.

出版信息

Mol Psychiatry. 2006 Dec;11(12):1113-5. doi: 10.1038/sj.mp.4001913. Epub 2006 Oct 10.

DOI:10.1038/sj.mp.4001913
PMID:17033629
Abstract

Hematopoietic stem cells contribute to mammalian brain tissue regeneration by transdifferentiation processes. We found decreased counts of circulating CD34+ cells in early Alzheimer's dementia (AD; P = 0.01), which significantly correlated with age (r = -0.661; P = 0.001), cerebrospinal fluid beta-amyloid (Abeta)1-42 (r = -0.467; P = 0.025) and most pronounced the Abeta42/40 ratio (r = -0.688; P = 0.005). Our data suggest a deficient regenerative hematopoietic support for the central nervous system in early AD.

摘要

造血干细胞通过转分化过程促进哺乳动物脑组织再生。我们发现,早期阿尔茨海默病(AD)患者循环CD34+细胞计数减少(P = 0.01),这与年龄(r = -0.661;P = 0.001)、脑脊液β-淀粉样蛋白(Aβ)1-42(r = -0.467;P = 0.025)显著相关,与Aβ42/40比值的相关性最为显著(r = -0.688;P = 0.005)。我们的数据表明,早期AD患者中枢神经系统的造血再生支持不足。

相似文献

1
Decreased circulating CD34+ stem cells in early Alzheimer's disease: Evidence for a deficient hematopoietic brain support?早期阿尔茨海默病患者循环CD34+干细胞减少:造血系统对脑支持不足的证据?
Mol Psychiatry. 2006 Dec;11(12):1113-5. doi: 10.1038/sj.mp.4001913. Epub 2006 Oct 10.
2
Prediction of Alzheimer's disease using the CSF Abeta42/Abeta40 ratio in patients with mild cognitive impairment.利用脑脊液β淀粉样蛋白42/β淀粉样蛋白40比值预测轻度认知障碍患者的阿尔茨海默病
Dement Geriatr Cogn Disord. 2007;23(5):316-20. doi: 10.1159/000100926. Epub 2007 Mar 19.
3
Cerebrospinal fluid {beta}-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain.脑脊液β淀粉样蛋白42和tau蛋白作为大脑中阿尔茨海默病型病理变化的生物标志物。
Arch Neurol. 2009 Mar;66(3):382-9. doi: 10.1001/archneurol.2008.596.
4
Oligomerization partially explains the lowering of Abeta42 in Alzheimer's disease cerebrospinal fluid.寡聚化部分解释了阿尔茨海默病脑脊液中β淀粉样蛋白42水平的降低。
Neurodegener Dis. 2009;6(4):139-47. doi: 10.1159/000225376. Epub 2009 Jun 12.
5
Plasma biomarkers of Alzheimer's disease.阿尔茨海默病的血浆生物标志物
Curr Opin Psychiatry. 2008 May;21(3):260-7. doi: 10.1097/YCO.0b013e3282fc989f.
6
Plasma Abeta levels do not reflect brain Abeta levels.血浆β淀粉样蛋白水平不能反映大脑β淀粉样蛋白水平。
J Neuropathol Exp Neurol. 2007 Apr;66(4):264-71. doi: 10.1097/NEN.0b013e31803d3ae4.
7
Concentrations of metals, beta-amyloid and tau-markers in cerebrospinal fluid in patients with Alzheimer's disease.阿尔茨海默病患者脑脊液中金属、β-淀粉样蛋白和tau蛋白标志物的浓度。
Dement Geriatr Cogn Disord. 2009;28(1):88-94. doi: 10.1159/000233353. Epub 2009 Aug 12.
8
Cerebrospinal fluid neuron-specific enolase: a further marker of Alzheimer's disease?脑脊液神经元特异性烯醇化酶:阿尔茨海默病的又一标志物?
Funct Neurol. 2008 Apr-Jun;23(2):93-6.
9
Association between acetylcholinesterase and beta-amyloid peptide in Alzheimer's cerebrospinal fluid.阿尔茨海默病脑脊液中乙酰胆碱酯酶与β-淀粉样肽之间的关联。
Chem Biol Interact. 2008 Sep 25;175(1-3):209-15. doi: 10.1016/j.cbi.2008.04.047. Epub 2008 May 7.
10
An Alzheimer's disease-specific beta-amyloid fragment signature in cerebrospinal fluid.脑脊液中阿尔茨海默病特异性β-淀粉样蛋白片段特征
Neurosci Lett. 2006 Dec 6;409(3):215-9. doi: 10.1016/j.neulet.2006.09.044. Epub 2006 Oct 17.

引用本文的文献

1
Radiomic and proteomic signatures of body mass index on brain ageing and Alzheimer's-like patterns of brain atrophy.体重指数对脑老化及阿尔茨海默病样脑萎缩模式的放射组学和蛋白质组学特征
EBioMedicine. 2025 Jun;116:105763. doi: 10.1016/j.ebiom.2025.105763. Epub 2025 May 27.
2
CD34+ Hematopoietic Stem Cell Counts in Alzheimer's Disease: A Meta-Analysis.阿尔茨海默病中CD34 +造血干细胞计数:一项荟萃分析。
Diseases. 2025 Jan 21;13(2):25. doi: 10.3390/diseases13020025.
3
An Investigation of the Inflammatory Landscape in the Brain and Bone Marrow of the APP/PS1 Mouse.
APP/PS1小鼠脑和骨髓中炎症图谱的研究
J Alzheimers Dis Rep. 2024 Jun 21;8(1):981-998. doi: 10.3233/ADR-240024. eCollection 2024.
4
The association between circulating CD34+CD133+ endothelial progenitor cells and reduced risk of Alzheimer's disease in the Framingham Heart Study.弗雷明汉心脏研究中循环CD34+CD133+内皮祖细胞与阿尔茨海默病风险降低之间的关联。
Explor Med. 2024;5(2):193-214. doi: 10.37349/emed.2024.00216. Epub 2024 Apr 12.
5
Peripheral extracellular vesicles in neurodegeneration: pathogenic influencers and therapeutic vehicles.神经退行性疾病中外周细胞外囊泡:致病影响因子和治疗载体。
J Nanobiotechnology. 2024 Apr 12;22(1):170. doi: 10.1186/s12951-024-02428-1.
6
Mitochondrial Dysfunction in Endothelial Progenitor Cells: Unraveling Insights from Vascular Endothelial Cells.内皮祖细胞中的线粒体功能障碍:从血管内皮细胞中获得的见解
Biology (Basel). 2024 Jan 23;13(2):70. doi: 10.3390/biology13020070.
7
Research progress in clinical trials of stem cell therapy for stroke and neurodegenerative diseases.干细胞治疗中风和神经退行性疾病的临床试验研究进展
Ibrain. 2023 Mar 5;9(2):214-230. doi: 10.1002/ibra.12095. eCollection 2023 Summer.
8
Blood-Derived Progenitor Cells Are Depleted in Older Adults with Cognitive Impairment: A Role for Vascular Resilience?血液源性祖细胞在认知障碍的老年人中耗竭:与血管弹性有关?
J Alzheimers Dis. 2023;93(3):1041-1050. doi: 10.3233/JAD-220269.
9
Biomarkers Assessing Endothelial Dysfunction in Alzheimer's Disease.评估阿尔茨海默病患者血管内皮功能障碍的生物标志物。
Cells. 2023 Mar 22;12(6):962. doi: 10.3390/cells12060962.
10
Endothelial Progenitor Cells in Neurovascular Disorders-A Comprehensive Overview of the Current State of Knowledge.神经血管疾病中的内皮祖细胞——当前知识状态的全面概述
Biomedicines. 2022 Oct 18;10(10):2616. doi: 10.3390/biomedicines10102616.